2 unchanged sentences
3.2 Bylaws of the Company, as amended effective June 28, 2022, incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on June 28, 2022.
−Removed: 4.6 (p) Form of the 4.100% Notes due 2032, incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 29, 2022.
−Removed: (q) Form of the 4.550% Notes due 2052, incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on April 29, 2022.
4.7 Upon the request of the U.S.
Securities and Exchange Commission, the Company will furnish copies of any other instruments defining the rights of holders of long-term debt of the Company or its subsidiaries.
−Removed: 10.2 * 2017 Elevance Health Incentive Compensation Plan, as amended and restated effective June 28, 2022.
−Removed: * (l) Form of Incentive Compensation Plan Nonqualified Stock Option Award Agreement for 2022, as amended and restated effective June 28, 2022.
−Removed: * (m) Form of Incentive Compensation Plan Restricted Stock Unit Award Agreement for 2022, as amended and restated effective June 28, 2022.
−Removed: * (n) Form of Incentive Compensation Plan Performance Stock Unit Award Agreement for 2022, as amended and restated effective June 28, 2022.
−Removed: 10.3 * Elevance Health Comprehensive Nonqualified Deferred Compensation Plan, as amended and restated effective June 28, 2022.
−Removed: 10.4 * Elevance Health Executive Agreement Plan, as amended and restated effective June 28, 2022.
−Removed: 10.5 * Elevance Health Executive Salary Continuation Plan, as amended and restated effective June 28, 2022.
−Removed: 10.6 * Elevance Health Directed Executive Compensation Plan, as amended and restated effective June 28, 2022.
−Removed: 10.7 * Elevance Health Board of Directors Compensation Program, as amended and restated effective June 28, 2022.
−Removed: 10.8 * Elevance Health Board of Directors’ Deferred Compensation Plan, as amended and restated effective June 28, 2022.
31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act Rules, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101 The following material from Elevance Health, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in Inline XBRL (Inline Extensible Business Reporting Language):
+Added: 101 The following material from Elevance Health, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL (Inline Extensible Business Reporting Language):
(i) the Consolidated Balance Sheets;
6 unchanged sentences
104 Cover Page Interactive Data File formatted in Inline XBRL and contained in Exhibit 101.
−Removed: *Indicates management contracts or compensatory plans or arrangements
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ELEVANCE HEALTH, INC.
−Removed: July 20, 2022 By:
+Added: October 19, 2022 By:
/ S / J OHN E.
1 unchanged sentence
(Duly Authorized Officer and Principal Financial Officer)
−Removed: July 20, 2022 By:
+Added: October 19, 2022 By:
/ S / R ONALD W.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.